SETD2: an epigenetic modifier with tumor suppressor functionalityJun Li, Klaas Kok|Oncotarget|2016Cited by 167
Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic DiseaseFrancisca Dias, Rui Medeiros, Bruno Costa‐Silva et al.|Cancers|2020Cited by 51
High expression of calcium‐binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphomaRenata Rust, Anke van den Berg, Judith van der Leij et al.|British Journal of Haematology|2005Cited by 48
Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot StudyFrancisca Dias, Rui Medeiros, Ana Luísa Teixeira et al.|International Journal of Molecular Sciences|2020Cited by 20
Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIsJun Li, Yongjun Guo, Cuiyun Zhang et al.|Holistic Integrative Oncology|2024Cited by 4